GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Inventories, Raw Materials & Components

Shire (SHPG) Inventories, Raw Materials & Components : $827 Mil (As of Sep. 2018)


View and export this data going back to 1998. Start your Free Trial

What is Shire Inventories, Raw Materials & Components?

Shire's inventories, raw materials & components for the quarter that ended in Sep. 2018 was $827 Mil.

Shire's quarterly raw materials increased from Mar. 2018 ($0 Mil) to Jun. 2018 ($801 Mil) and increased from Jun. 2018 ($801 Mil) to Sep. 2018 ($827 Mil).

Shire's annual raw materials increased from Dec. 2015 ($149 Mil) to Dec. 2016 ($691 Mil) and increased from Dec. 2016 ($691 Mil) to Dec. 2017 ($791 Mil).

Shire Inventories, Raw Materials & Components Historical Data

The historical data trend for Shire's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Inventories, Raw Materials & Components Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.20 103.50 148.50 691.30 791.40

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 769.50 791.40 - 800.50 827.40

Shire Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Shire (SHPG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
VRTX REGN ASX:CSL ALXN XKRX:207940 SGEN INCY XKRX:068270 HKSE:01177 XBRU:UCB OCSE:GMAB HKSE:02269 BMRN HKSE:06160 XAMS:GLPG ALNY ARRY NBIX SZSE:300122 IONS
Traded in Other Exchanges
N/A
Address
Website
http://www.shire.com
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085